Clinical Trials on Narcotic Consumption

Total 1791 results

Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 3 - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Assessment of Tramadol as a Treatment for Opioid Addiction

Opioid-Related Disorders

United States
US Department of Veterans Affairs

Completed

Effect Of Case Management Following Discharge From Methadone Treatment

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
Cairo University

Not yet recruiting

Rosmarinus Officinalis Versus 2.5%Sodium Hypochlorite as Root Canal Irrigants

Necrotic Pulp
Cairo University

Unknown

Comparative Evaluation of the Regenerative Capacity of Two Platelet Concentrates

Necrotic Pulp
Enas Ebrahim Sayed

Completed

Pulp Revascularization Versus MTA Apexification (RCT)

Necrotic Pulp
CAMC Health System

Recruiting

Pregabalin vs. Gabapentin on Reducing Opioid Usage

Pain | Trauma | Injuries | Analgesics | Gabapentin | Narcotics

United States
Scripps Health

Not yet recruiting

Duloxetine Impact on Postoperative Pain Control and Outcomes

Opioid Use | Chronic Post Operative Pain | Narcotic Use | Opioid Addiction | Acute Post-operative Pain
University of Oregon
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA) (ISLA)

Opioid Misuse
Western Michigan University
National Institute on Drug Abuse (NIDA); RTI International; DynamiCare Health...

Recruiting

OUD Smartphone Services

Opioid-Related Disorders | Drug Abuse

United States
PATH
London School of Hygiene and Tropical Medicine; Monash University; University... and other collaborators

Not yet recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Opioid Dependence
Wake Forest University Health Sciences
University of North Carolina, Chapel Hill; University of Kentucky; East Carolina...

Recruiting

Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids

Opioid Misuse

United States
VA Office of Research and Development

Recruiting

A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment

Dependence, Opioid

United States
Texas Christian University
University of New Mexico; Loyola University

Recruiting

Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center (JCOIN_TCU)

Addiction, Opioid

United States
Stanford University
Patient-Centered Outcomes Research Institute

Recruiting

Integrating Support Persons Into Recovery (INSPIRE)

Opioid Addiction

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Naltrexone for Pre-release Prisoners

Opiate Addiction

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Facilitating Rapid Naltrexone Initiation

Opioid Dependence

United States
University of Maryland, Baltimore

Completed

Social Work Assistance and Stipends for Housing (SASH) (SASH)

Opioid-Related Disorders | Housing Problems

United States
Jessica Morgan
Temple University

Completed

Decreasing Opioid Misuse and Habit-forming Behaviors Following Prescription in Patients Undergoing Cesarean Section

Opioid Misuse

United States
Potomac Health Foundations

Completed

Treatment of Opioid Use: Medication Adherence Therapy (MAT-PLUS)

Opioid-Related Disorders | Opioid Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

A Digital Intervention to Prevent Initiation of Opioid Misuse in Adolescents in School-based Health Centers

Opioid Misuse

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Counseling for Primary Care Office-based Buprenorphine

Opiate Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Study of Computer-Based Treatment for Drug Dependence (RLSS)

Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
University Hospital, Clermont-Ferrand
UFR Pharmacie (Clermont-Ferrand)

Completed

Evaluation of Pharmacy Students' Perception of Opioid / Opiate Dependence (STUD_TOX)

Opioid-Related Disorders

France
University of Pennsylvania
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Opioid-Related Disorders | Heroin Dependence

United States, Russian Federation
Titan Pharmaceuticals

Completed

A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants (PRO-814)

Opioid Dependence
Acura Pharmaceuticals Inc.
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Completed

Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users

Opioid Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine and Naltrexone Treatment for Opioid Dependence (NAMHS-1)

Opioid Dependence

United States
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects (YHO)

Opioid-Related Disorders | Heroin Dependence

United States
University of Pennsylvania

Completed

Remote Observed Dosing to Increase Suboxone Compliance (RODISC)

Opiate Dependence

United States
New York State Psychiatric Institute
Indivior Inc.

Completed

Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone

Heroin Dependence

United States
University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Withdrawn

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

Opioid-Related Disorders | Heroin Dependence

United States
BioDelivery Sciences International

Withdrawn

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

Opioid Dependence

United States
BioDelivery Sciences International

Withdrawn

Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects

Opioid Dependence

United States
BioDelivery Sciences International

Completed

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

Opioid Dependence

United States
Alkermes, Inc.

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Opiate Dependence

Russian Federation
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens

Opioid-Related Disorders | Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1

Heroin Dependence

United States
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
Butler Hospital

Completed

Distress Tolerance and Buprenorphine (TRUST)

Opioid Dependence

United States
MacDonald, Kai, M.D.

Unknown

Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence

Opiate Dependence

United States

Clinical Trials on Narcotic Consumption

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations